4594.T
BrightPath Biotherapeutics Co.,Ltd.
グロース · 医薬品 · 医薬品 · JP
JPY 52.00
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-116.2%
Return on equity
-94.6%
Return on assets
-117.1%
Return on invested capital
0.00x
Asset turnover
-JPY 1.3B
Cash from operations
JPY 8.36
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026